USANA Health Sciences, Inc. (USNA)

USANA Health Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	63.79	69.35	116.51	124.66	100.53
Depreciation & Amortization	20.4	21.41	22.19	22.51	23.01
Share-Based Compensation	14.6	13.33	14.3	14.39	15.54
Other Operating Activities	-28.14	-0.19	-31.77	-1.17	-12.34
Operating Cash Flow	70.64	103.9	121.23	160.4	126.73
Operating Cash Flow Growth	-32.01%	-14.29%	-24.42%	26.57%	-16.69%
Capital Expenditures	-14.48	-10.39	-12.75	-15.09	-16.55
Acquisitions	0	-6.53	0	0	0
Change in Investments	2.5	4.56	-1.44	-18.87	64.05
Investing Cash Flow	-11.98	-12.37	-14.19	-33.96	47.49
Share Issuance / Repurchase	-11.6	-25.38	-177.84	-57.03	-150
Debt Issued / Paid	0.79	0	0	-0.05	-0.07
Other Financing Activities	-3.43	-4.71	-3.58	-2.37	-1.99
Financing Cash Flow	-14.24	-30.09	-181.41	-59.44	-152.05
Exchange Rate Effect	-2.5	-13.78	2.09	11.25	-1.72
Net Cash Flow	41.93	47.67	-72.28	78.25	20.45
Free Cash Flow	56.16	93.51	108.48	145.31	110.18
Free Cash Flow Growth	-39.94%	-13.80%	-25.35%	31.89%	-21.89%
Free Cash Flow Margin	6.10%	9.36%	9.14%	12.81%	10.39%
Free Cash Flow Per Share	2.92	4.86	5.38	6.87	4.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).